A vision for growth, shaped by experience.

Ms. Androski joined Arbutus in February 2025 as President and CEO and Chairperson of the Board. Ms. Androski, an MIT-trained biologist, has nearly 30 years of experience in biotechnology, law, and academia. She has served in a variety of roles at Roivant including President and CEO of Roivant Social Ventures and Vice President, Head of Acquisitions. At Roivant she built and led the team responsible for the in-licensing or acquisition of more than 30 therapeutic programs, resulting in the launch and incubation of 16 subsidiary biotechs and several successful IPOs. Prior to joining Roivant, Ms. Androski spent more than a decade as a trial lawyer, including as an Assistant U.S. Attorney in the Eastern District of Virginia. Earlier in her career, Ms. Androski was a strategy consultant advising Fortune 100 clients on merger integration and other business challenges. She is currently a member of the board of directors at Eloxx Pharma. Ms. Androski holds two Bachelor of Science degrees from the Massachusetts Institute of Technology, JD and MBA degrees from The University of Chicago, is a registered Patent Lawyer and a CFA charterholder. She serves as a Trustee of MIT, where she Chairs the Visiting Committee for the Department of Chemistry, and sits on the Visiting Committees for the Department of Biology, the Department of Humanities, Sponsored Research, and the Advisory Board of the MIT Press.

Mr. Nguyen joined Arbutus in March 2025 as Chief Financial Officer. Mr. Nguyen has more than 15 years of strategic finance experience with biopharma companies in various stages of development. Over his career, he raised $2B in capital and successfully closed a partnership deal with AstraZeneca valued at $2.2B. Most recently, Tuan was CFO at Kinevant Sciences where he led finance and operation functions and implemented structure and processes within the organization to fuel growth opportunities. Prior to that he held various senior finance leadership roles at Adverum Biotechnologies, Intarcia Therapeutics, Fibrogen, and UCB. Tuan earned his MBA with dual concentration in Finance and Entrepreneurship, Innovation, & Change from Emory University and BS in Finance from Louisiana Tech University.

Ms. Caperelli joined Arbutus in September 2021 as Vice President Investor Relations. Ms. Caperelli has more than 20 years of demonstrated experience in leading investor communication strategies for publicly traded biotechnology companies. Prior to joining Arbutus, Lisa oversaw investor relations at Harmony Biosciences, where she assisted the company in its IPO and prepared the investment community for the companies launch of its first FDA approved product. Throughout her career, Ms. Caperelli held roles of increased responsibility in investor relations and corporate communications with several small- to mid-cap biotech companies at various stages of development including Marinus Pharmaceuticals, Advaxis, Inc., PolyMedix and Windtree Therapeutics, Inc. (formerly Discovery Labs). In these roles, Ms. Caperelli has been instrumental in providing strategic guidance, securing capital through various types of financings, and concisely communicating the company’s strategy, growth opportunities and business initiatives to key stakeholders. Ms. Caperelli holds a Bachelor of Science in Business Administration from Delaware Valley University. She is a board member of NIRI: The Association for Investor Relations and Advisors, immediate past president of the NIRI Philadelphia Chapter and a member of the Delaware Valley University President’s Advisory Council.

Ms. Briscoe joined Arbutus in July 2021 and serves as Vice President, Human Resources.  Ms. Briscoe has more than 15 years of Human Resources generalist experience with the last 6 years spent in the life sciences industry. Throughout her career, she has focused on compensation & benefits, performance management, employee relations, training and development, recruitment, workers compensation, human resources information systems, diversity, equity and inclusion efforts, and ESG initiatives.  Prior to Arbutus, Ms. Briscoe was a member of the Human Resources team at Lannett Company, a leading manufacturer of pharmaceutical products, where she implemented and oversaw employee benefits and compensation for more than 1000 employees.  Additionally, her career has included HR roles of increasing responsibility with privately owned manufacturing and wholesale companies, and one of the largest school districts in Pennsylvania.  Ms. Briscoe holds a B.A. from University of Delaware, a Senior Professional in Human Resources Certificate, as well as a SHRM (Society for Human Resources) Senior Certified Professional Certificate.